tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Orchitis D009920 1 associated lipids
Optic Neuritis D009902 1 associated lipids
Opportunistic Infections D009894 8 associated lipids
Oliguria D009846 2 associated lipids
Obesity D009765 29 associated lipids
Nocardia Infections D009617 6 associated lipids
Neutropenia D009503 15 associated lipids
Neuromyelitis Optica D009471 2 associated lipids
Neuromuscular Diseases D009468 10 associated lipids
Neurodermatitis D009450 1 associated lipids
Neuritis D009443 4 associated lipids
Nervous System Diseases D009422 37 associated lipids
Nerve Degeneration D009410 53 associated lipids
Nephrotic Syndrome D009404 11 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Nephritis, Hereditary D009394 1 associated lipids
Nephritis D009393 19 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Necrobiosis Lipoidica D009335 2 associated lipids
Nail Diseases D009260 2 associated lipids
Myxedema D009230 2 associated lipids
Myelitis D009187 1 associated lipids
Mycoses D009181 18 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Myasthenia Gravis D009157 5 associated lipids
Mutism D009155 1 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Multiple Myeloma D009101 13 associated lipids
Moyamoya Disease D009072 1 associated lipids
Mouth Diseases D009059 5 associated lipids
Molluscum Contagiosum D008976 2 associated lipids
Mite Infestations D008924 1 associated lipids
Metaplasia D008679 7 associated lipids
Meningoencephalitis D008590 4 associated lipids
Meningococcal Infections D008589 3 associated lipids
Memory Disorders D008569 33 associated lipids
Melanoma D008545 69 associated lipids
Megacolon, Toxic D008532 1 associated lipids
Mediastinitis D008480 2 associated lipids
Mediastinal Emphysema D008478 1 associated lipids
Mediastinal Diseases D008477 1 associated lipids
Mastocytosis D008415 5 associated lipids
Malocclusion, Angle Class II D008312 1 associated lipids
Malacoplakia D008287 1 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Lymphomatoid Granulomatosis D008230 2 associated lipids
Lymphoma D008223 18 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Lymphocele D008210 1 associated lipids
Lupus Nephritis D008181 8 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Erythematosus, Discoid D008179 1 associated lipids
Lupus Erythematosus, Cutaneous D008178 2 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Abscess D008169 1 associated lipids
Long QT Syndrome D008133 10 associated lipids
Liver Diseases D008107 31 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Abscess D008100 6 associated lipids
Listeriosis D008088 12 associated lipids
Lichen Planus D008010 3 associated lipids
Leukoplakia, Oral D007972 1 associated lipids
Leukoplakia D007971 1 associated lipids
Leukocytosis D007964 9 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukemia P388 D007941 43 associated lipids
Leukemia D007938 74 associated lipids
Lentigo D007911 1 associated lipids
Legionellosis D007876 3 associated lipids
Leg Injuries D007869 2 associated lipids
Labyrinthitis D007762 2 associated lipids
Vulvar Lichen Sclerosus D007724 1 associated lipids
Kidney Tubular Necrosis, Acute D007683 3 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Kidney Diseases D007674 29 associated lipids
Keloid D007627 12 associated lipids
Kartagener Syndrome D007619 2 associated lipids
Kaposi Varicelliform Eruption D007617 1 associated lipids
Ischemia D007511 18 associated lipids
Intussusception D007443 1 associated lipids
Intestinal Pseudo-Obstruction D007418 5 associated lipids
Intestinal Fistula D007412 1 associated lipids
Intestinal Atresia D007409 3 associated lipids
Intertrigo D007402 1 associated lipids
Insulin Resistance D007333 99 associated lipids
Influenza, Human D007251 11 associated lipids
Inflammation D007249 119 associated lipids
Infection D007239 6 associated lipids
Incontinentia Pigmenti D007184 2 associated lipids
Inappropriate ADH Syndrome D007177 4 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Impetigo D007169 3 associated lipids
Immune System Diseases D007154 3 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Epperla N et al. Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy. 2017 Transfusion pmid:28836275
Müller EG et al. Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial. 2017 Arq Bras Oftalmol pmid:28832739
Slocum AMY A surgeon's nightmare: pyoderma gangrenosum with pathergy effect mimicking necrotising fasciitis. 2017 BMJ Case Rep pmid:29269363
Charlton M et al. Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study. 2017 Transplantation pmid:28817434
Ghaffari R et al. Tacrolimus Eye Drops as Adjunct Therapy in Severe Corneal Endothelial Rejection Refractory to Corticosteroids. 2017 Cornea pmid:28817391
van der Merwe Y et al. An Elastomeric Polymer Matrix, PEUU-Tac, Delivers Bioactive Tacrolimus Transdurally to the CNS in Rat. 2017 EBioMedicine pmid:29208469
Kumai Y et al. Reversible Cerebral Vasoconstriction Syndrome After Heart Transplantation: A Case Report. 2017 Transplant. Proc. pmid:29198694
Tolkachjov SN et al. Frontal fibrosing alopecia among men: A clinicopathologic study of 7 cases. 2017 J. Am. Acad. Dermatol. pmid:28716436
Ahn SW et al. A multicenter prospective observational study on the safety and efficacy of tacrolimus in patients with myasthenia gravis. 2017 J. Neurol. Sci. pmid:28716258
Savić V et al. Tacrolimus loaded biocompatible lecithin-based microemulsions with improved skin penetration: Structure characterization and in vitro/in vivo performances. 2017 Int J Pharm pmid:28711641
Montenovo MI et al. Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients. 2017 Exp Clin Transplant pmid:27309029
Groll AH et al. Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults. 2017 Clin Pharmacol Drug Dev pmid:27273343
Das B et al. Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients. 2017 Pediatr Transplant pmid:27862703
Tamashiro EY et al. Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients. 2017 Drug Metab Pers Ther pmid:28593920
Srinivas NR Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. 2017 Aliment. Pharmacol. Ther. pmid:28589592
Benítez C et al. Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. Authors' reply. 2017 Aliment. Pharmacol. Ther. pmid:28589580
Gerlach UA et al. Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation. 2017 Transplantation pmid:27607529
Fai D et al. Duration of response in vitiligo lesions after narrowband UVB phototherapy combined with tacrolimus ointment. 2017 G Ital Dermatol Venereol pmid:28621124
Efe C et al. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. 2017 Clin. Gastroenterol. Hepatol. pmid:28603052
Ramirez R et al. Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report. 2017 Am J Case Rep pmid:28465499
Aguiar D et al. Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients. 2017 Ann. Transplant. pmid:28461684
Justice JA et al. Disruption of K2.1 somato-dendritic clusters prevents the apoptogenic increase of potassium currents. 2017 Neuroscience pmid:28461216
Lu XF et al. Use of a semi-physiological pharmacokinetic model to investigate the influence of itraconazole on tacrolimus absorption, distribution and metabolism in mice. 2017 Xenobiotica pmid:27533047
O'Leary JG Editorial: tacrolimus-how low can you go? 2017 Aliment. Pharmacol. Ther. pmid:28589579
Zheng X et al. Effect of FK-506 (tacrolimus) therapy on bone healing of titanium implants: a histometric and biomechanical study in mice. 2017 Eur. J. Oral Sci. pmid:27935130
Song K et al. Engineering of the LysR family transcriptional regulator FkbR1 and its target gene to improve ascomycin production. 2017 Appl. Microbiol. Biotechnol. pmid:28349163
Ikeguchi R et al. Recipient bone marrow-derived stromal cells prolong graft survival in a rat hind limb allotransplantation model. 2017 Microsurgery pmid:27859595
Kodama S et al. Tacrolimus-Induced Reversible Cerebral Vasoconstriction Syndrome with Delayed Multi-Segmental Vasoconstriction. 2017 J Stroke Cerebrovasc Dis pmid:28342655
Salgüero Fernández I et al. Rapidly progressive infiltrated plaques in a transplant recipient. 2017 Actas Dermosifiliogr pmid:27677210
Wan T et al. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities. 2017 Int J Nanomedicine pmid:28260894
Stojanovic J et al. Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation. 2017 Transplantation pmid:27463537
Moes AD et al. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial. 2017 Am. J. Kidney Dis. pmid:28259499
Basu B et al. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children. 2017 Clin. Exp. Nephrol. pmid:27108294
Moiseev IS et al. Pharmacokinetic comparison of cyclosporin A and tacrolimus in graft-versus-host disease prophylaxis. 2017 Ann. Hematol. pmid:28343273
Tremblay S et al. A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. 2017 Am. J. Transplant. pmid:27340950
Dobbels F et al. Efficacy of a medication adherence enhancing intervention in transplantation: The MAESTRO-Tx trial. 2017 J. Heart Lung Transplant. pmid:28162931
Grant CR et al. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis. 2017 Clin. Exp. Immunol. pmid:28257599
Qin HZ et al. Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients. 2017 BMC Nephrol pmid:28056860
Kim D et al. FK506, an Immunosuppressive Drug, Induces Autophagy by Binding to the V-ATPase Catalytic Subunit A in Neuronal Cells. 2017 J. Proteome Res. pmid:28056508
Noda K et al. Tacrolimus-induced hypertrophic cardiomyopathy in a patient with dermatomyositis. 2017 Rheumatology (Oxford) pmid:28977571
Wang J et al. Metabolic network model guided engineering ethylmalonyl-CoA pathway to improve ascomycin production in Streptomyces hygroscopicus var. ascomyceticus. 2017 Microb. Cell Fact. pmid:28974216
Ordóñez-Robles M et al. Analysis of the Pho regulon in Streptomyces tsukubaensis. 2017 Microbiol. Res. pmid:28942849
Jia Y et al. Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium. 2017 Ther Drug Monit pmid:27941535
Cohen JB et al. Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study. 2017 Transplantation pmid:27941427
Kaneko T et al. Effectiveness of Measuring Genetic Polymorphisms in Metabolizing Enzymes of Tacrolimus within One Medical Facility. 2017 J Nippon Med Sch pmid:29279557
Terakura S et al. Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil. 2017 Bone Marrow Transplant. pmid:27941766
Kannegieter NM et al. Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14+ Monocytes After Kidney Transplantation. 2017 Ther Drug Monit pmid:28640063
Andrade LM et al. Improved tacrolimus skin permeation by co-encapsulation with clobetasol in lipid nanoparticles: Study of drug effects in lipid matrix by electron paramagnetic resonance. 2017 Eur J Pharm Biopharm pmid:28627400
Baas M et al. Unique clinical conditions associated with different acinar regions of fibrosis in long-term surviving pediatric liver grafts. 2017 Pediatr Transplant pmid:28627016
Vanhove T et al. Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients. 2017 Ther Drug Monit pmid:27861314